Advanced Solid Tumors: PM54 Treatment Study

We are testing a new drug called PM54 in patients with advanced solid tumors to see how safe it is and how it works. This study aims to explore new treatment options for those with limited choices.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Hospital Hm Nou Delfos
START Barcelona- HM Nou Delfos
Barcelona, Spain
University Hospital Virgen Del Rocio S.L.
Oncology
Huelva, Spain
Hospital Universitario Quironsalud Madrid
NEXT Madrid Phase I trials
Pozuelo de Alarcón, Spain
Sponsor: Pharma Mar S.A.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.